-
1
-
-
0032480904
-
-
K.A. Metwally, M. Dukat, C.T. Egan, C. Smith, A. DuPre, C.B. Gauthier, K. Herrick-Davis, M. Teitler, and R.A. Glennon J. Med. Chem. 41 1998 5084 5093
-
(1998)
J. Med. Chem.
, vol.41
, pp. 5084-5093
-
-
Metwally, K.A.1
Dukat, M.2
Egan, C.T.3
Smith, C.4
Dupre, A.5
Gauthier, C.B.6
Herrick-Davis, K.7
Teitler, M.8
Glennon, R.A.9
-
2
-
-
0030745866
-
-
S. Samnick, W. Brandau, G. Noelken, H.J. Gerhards, and O. Schober Nucl. Med. Biol. 24 1997 295 303
-
(1997)
Nucl. Med. Biol.
, vol.24
, pp. 295-303
-
-
Samnick, S.1
Brandau, W.2
Noelken, G.3
Gerhards, H.J.4
Schober, O.5
-
3
-
-
78751593580
-
-
Ceccarelli S. M.; Pinard E.; Stalder H. WO2005040166.
-
Ceccarelli, S. M.; Pinard, E.; Stalder, H. WO2005040166.
-
-
-
-
4
-
-
63149128774
-
-
R. Lavieri, S.A. Scott, J.A. Lewis, P.E. Selvy, M.D. Armstrong, H.A. Brown, and C.W. Lindsley Biorg. Med. Chem. Lett. 19 2009 2240 2243
-
(2009)
Biorg. Med. Chem. Lett.
, vol.19
, pp. 2240-2243
-
-
Lavieri, R.1
Scott, S.A.2
Lewis, J.A.3
Selvy, P.E.4
Armstrong, M.D.5
Brown, H.A.6
Lindsley, C.W.7
-
5
-
-
78751598324
-
-
Goto, G.; Nagaoka, A. JP01207291.
-
Goto, G.; Nagaoka, A. JP01207291.
-
-
-
-
6
-
-
78751582693
-
-
Schlienger, N. WO2003057698.
-
Schlienger, N. WO2003057698.
-
-
-
-
7
-
-
78751582692
-
-
Baldwin, J. J.; Huff, J. R.; Vacca, J. P.; Young, S. D.; De Solms, J.; Guare, J. P. EP204254
-
Baldwin, J. J.; Huff, J. R.; Vacca, J. P.; Young, S. D.; De Solms, J.; Guare, J. P. EP204254.
-
-
-
-
9
-
-
78751587237
-
-
2. Prior to the initiation of a solid-phase reaction the resin is typically washed two times with the reaction solvent.
-
2. Prior to the initiation of a solid-phase reaction the resin is typically washed two times with the reaction solvent.
-
-
-
-
12
-
-
78751588895
-
-
The Alloc protecting group was removed under the following conditions: a THF solution of 1,3-dimethylbarbituric acid (5.0 equiv) was degassed with argon prior to the addition to the resin. Tetrakis(triphenylphosphine)palladium(0) (0.25 equiv) was then added as a solid and the resulting resin suspension shaken for 18 h at 25 °C.
-
The Alloc protecting group was removed under the following conditions: a THF solution of 1,3-dimethylbarbituric acid (5.0 equiv) was degassed with argon prior to the addition to the resin. Tetrakis(triphenylphosphine)palladium(0) (0.25 equiv) was then added as a solid and the resulting resin suspension shaken for 18 h at 25 °C.
-
-
-
-
13
-
-
78751587238
-
-
Analytical standards of 17a-f were synthesized using the combined solution-phase and solid-phase approach described in this Letter, and purified by semi-preparative HPLC. Analytical HPLC analysis was conducted using a PDA-linked Waters Millenium 2690 and Phenomenex Luna 3um 50 × 3 mm C8 column.
-
Analytical standards of 17a-f were synthesized using the combined solution-phase and solid-phase approach described in this Letter, and purified by semi-preparative HPLC. Analytical HPLC analysis was conducted using a PDA-linked Waters Millenium 2690 and Phenomenex Luna 3um 50 × 3 mm C8 column.
-
-
-
|